Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Advances in Covalent Drug Discovery
D. M. Schaefer, Xinlai Cheng
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 663-663
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 80
Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection
Gerd Heusch, Ioanna Andreadou, Robert M. Bell, et al.
Redox Biology (2023) Vol. 67, pp. 102894-102894
Open Access | Times Cited: 47
Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and Future Perspectives
Jiahao Li, Gong Chen, Haiting Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5489-5489
Open Access | Times Cited: 17
Biomimetic Synthesis and Chemical Proteomics Reveal the Mechanism of Action and Functional Targets of Phloroglucinol Meroterpenoids
Amy K. Bracken, Colby E. Gekko, Nina O. Suss, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 4, pp. 2524-2548
Open Access | Times Cited: 7
The expanding repertoire of covalent warheads for drug discovery
Namrashee V. Mehta, Mariam S. Degani
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103799-103799
Closed Access | Times Cited: 20
Chemical technology principles for selective bioconjugation of proteins and antibodies
Preeti Chauhan, V. Ragendu, Mohan Kumar, et al.
Chemical Society Reviews (2023) Vol. 53, Iss. 1, pp. 380-449
Closed Access | Times Cited: 18
Development of Receptor Desolvation Scoring and Covalent Sampling in DOCK 6: Methods Evaluated on a RAS Test Set
Yu-Hong Tan, Mayukh Chakrabarti, Reed M. Stein, et al.
Journal of Chemical Information and Modeling (2025)
Open Access
Disrupted target binding with acryloyl group as potential Bcr-Abl/C-Src dual kinase inhibitor optimization strategies with maintained antitumor activity
Ching‐Fuh Lin, Hsin-Yi Chiang, Grace Shiahuy Chen, et al.
Bioorganic & Medicinal Chemistry Letters (2025) Vol. 119, pp. 130105-130105
Closed Access
Aromatic nitroolefin with inhibition efficacy in triple-negative breast cancer cells by dual targeting RXRα and tubulins
Xian‐Jun Qu, Yanxia Wang, Yunqing Xu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117486-117486
Closed Access
Identification of Small Covalent Inhibitors Targeting DsbA Using Virtual Screening, Covalent Docking, and Molecular Dynamics Simulations
Yuxiang Ren, Ying Xin, Rongxi Zhu, et al.
Journal of Molecular Graphics and Modelling (2025), pp. 109017-109017
Closed Access
Pitfalls and Considerations in Determining the Potency and Mutant Selectivity of Covalent Epidermal Growth Factor Receptor Inhibitors
Kristopher W. Hoyt, Daniel A. Urul, Blessing C. Ogboo, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 1, pp. 2-16
Open Access | Times Cited: 14
Development of STING degrader with double covalent ligands
Miki Nakamura, Nobumichi Ohoka, Norihito Shibata, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 102, pp. 129677-129677
Closed Access | Times Cited: 4
Fitting of kinact and KI Values from Endpoint Pre-incubation IC50 Data
Lavleen Mader, Jeffrey W. Keillor
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 5, pp. 731-738
Closed Access | Times Cited: 4
Covalent drug – An emerging framework for targeted drug development
Ritesh Bhole, Govinda O. Joshi, Harshad S. Kapare, et al.
Results in Chemistry (2024) Vol. 8, pp. 101615-101615
Open Access | Times Cited: 4
CHARMM-GUI PDB Reader and Manipulator: Covalent Ligand Modeling and Simulation
Lingyang Kong, Sang‐Jun Park, Wonpil Im
Journal of Molecular Biology (2024) Vol. 436, Iss. 17, pp. 168554-168554
Closed Access | Times Cited: 3
Advanced technologies for screening and identifying covalent inhibitors
Yaolin Guo, Shuai Wen, Aiping Tong, et al.
TrAC Trends in Analytical Chemistry (2024) Vol. 178, pp. 117833-117833
Closed Access | Times Cited: 2
Systematic Targeting of Protein Complexes with Molecular COUPLrs
Diane Yang, Stefan Harry, Harrison B. Chong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 2
A Practical Guide for the Assay-Dependent Characterisation of Irreversible Inhibitors
Lavleen Mader, Jessica E. Borean, Jeffrey W. Keillor
RSC Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
Modular and Diverse Synthesis of Acrylamides by Palladium‐Catalyzed Hydroaminocarbonylation of Acetylene
Matthias Beller, Zhusong Cao, Qiang Wang, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 40
Open Access | Times Cited: 2
Novel partially reversible NDM-1 inhibitors based on the naturally occurring houttuynin
Lifang Wang, Yaowen Liang, Pan Luo, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107328-107328
Closed Access | Times Cited: 1
How should we teach medicinal chemistry in higher education to prepare students for a future career as medicinal chemists and drug designers? - A teacher´s perspective.
Philipp Klahn
(2024)
Open Access | Times Cited: 1
PDB-CAT: A User-Friendly Tool to Classify and Analyze PDB Protein-Ligand Complexes
Ariadna Llop-Peiró, Gerard Pujadas, Aleix Gimeno, et al.
(2024)
Open Access | Times Cited: 1
Trends in covalent drug discovery: a 2020-23 patent landscape analysis focused on select covalent reacting groups (CRGs) found in fda-approved drugs
Jan Felix Scholtes, Cristóbal Alhambra, Philip A. Carpino
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 10, pp. 843-861
Closed Access | Times Cited: 1
Advancements, challenges, and future frontiers in covalent inhibitors and covalent drugs: A review
Muhammad Salman Hameed, Hongxuan Cao, Li Guo, et al.
European Journal of Medicinal Chemistry Reports (2024), pp. 100217-100217
Open Access | Times Cited: 1
Advances in the Search for SARS-CoV-2 Mpro and PLpro Inhibitors
Marcel Arruda Diogo, Augusto Gomes Teixeira Cabral, Renata Barbosa de Oliveira
Pathogens (2024) Vol. 13, Iss. 10, pp. 825-825
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top